Cannabinoids

NEW YORK, Dec. 06, 2017 (GLOBE NEWSWIRE) — NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF), a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems. The publication, titled, “Purified […]

by

Cannabis derivatives have been used medicinally around the world for millennia. However, concerns surrounding potential dangers and abuse of marijuana’s psychoactive component THC (tetrahydrocannabinol) led to the banning of medicinal cannabis early in the 20th Century. Recent scientific studies, however, have given new credence to the wisdom from millennia ago and have scientifically proven the […]

by

As more Canadians than ever suffer chronic pain, the chase is on to find novel therapeutic approaches to effectively manage their conditions. In fact, BMC Public Health estimates that 20% of adults on a global level suffer from chronic pain while 10% are newly diagnosed every year. In Canada, chronic pain affects 1.5 million people. […]

by

Heavy marijuana use, for a small number of people, has been linked to a rare and mysterious illness which causes vomiting and stomach pain. The mysterious illness is called cannabinoid hyperemesis syndrome (CHS) and was discovered in 2004, according to NPR. However, cannabinoid hyperemesis syndrome didn’t receive much attention until recently, when doctors began to […]

by

Sleep apnea is estimated to affect 1 in 5 American adults, and there are currently no drugs available to treat it. But a large-scale clinical trial now offers hope, proving that a drug that uses a synthetic version of the main psychoactive substance in cannabis is effective for treating the disorder. A synthetic version of […]

by

The medical community has only recently recognized cannabinoid hyperemesis syndrome as an actual condition. In fact, the first link between marijuana and vomiting surfaced in published medical literature just 20 years ago, when researchers detailed an unusual case of cyclical vomiting in a 22-year-old man who used marijuana frequently. Still, they didn’t point to marijuana […]

by

BELOIT – Rock County authorities are seeing a decrease in the amount of synthetic cannabinoid use in the last year. Rock County Sheriff’s Office Commander Troy Knudson said the synthetic drugs were a significant problem for the county from late last year to earlier this year. However, he estimates cases have decreased over the last […]

by

MMJ International Holdings has applied to the U.S. Patent and Trademark Office (USPTO) for new pharmaceutical compounds and methods to treat and prevent symptoms associated with multiple sclerosis (MS) and other diseases responsive to cannabinoids. The patent covers MMJ BioScience’s intellectual property portfolio, which comprises several patent families with issued or pending claims regarding plants, […]

by

TORONTO, ONTARIO–(Marketwired – Nov. 29, 2017) – Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV)(OTCQB:RVVTF), a company focused on the research, development and commercialization of novel therapies and technologies for the medical cannabis and pharmaceutical sectors, today announced successful final results from its research project with the University of Wisconsin-Madison for the development of […]

by

Performed in the Netherlands, a review of existing research on Cannabidiol – aka, the CBD cannabinoid found in marijuana – has underscored the compound’s efficacy as an antipsychotic medication. In another victory for Cannabidiol, the recent review of existing research has determined the CBD cannabinoid found in cannabis is more effective at reducing antipsychotic episodes […]

by